Unnecessary repeat requesting of tests: An audit in a government hospital immunology laboratory

Journal of Clinical Pathology

Volumn 58, Issue 5, 2005, Pages 457-462

  Kwok, J ^a   Jones, B ^a  

^a QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN; TUMOR MARKER;

ANTIBODY DETECTION; CLINICAL IMMUNOLOGY; COMPUTER SYSTEM; COST; HUMAN; INFORMATION RETRIEVAL; INFORMATION SYSTEM; LABORATORY; LABORATORY PERSONNEL; LABORATORY TEST; MEDICAL AUDIT; PRIORITY JOURNAL; PUBLIC HOSPITAL; REVIEW; WORKLOAD;

AUTOANTIBODIES; COSTS AND COST ANALYSIS; DIAGNOSTIC TESTS, ROUTINE; HUMANS; IMMUNOGLOBULINS; LABORATORIES, HOSPITAL; MEDICAL AUDIT; TUMOR MARKERS, BIOLOGICAL; UNNECESSARY PROCEDURES;

EID: 18444402817     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2004.021691     Document Type: Review

References (91)

1. Danzon PM, Manning WG Jr, Marquis MS. Factors affecting laboratory test use and prices. Health Care Financ Rev 1984;5:23-32.
2. Fowkes FG, Catford JC, Logan RF. Containing the use of laboratory tests. BMJ 1985;290:488-90.
3. Showstock JA, Schroeder SA, Matsumoto MF. Changes in the use of medical technologies, 1972-1977: a study of 10 inpatient diagnoses. N Engl J Med 1982;306:706-12.
4. Epstein AM, McNeil BJ. Physician characteristics and organizational factors influencing use of ambulatory tests. Med Decis Making 1985;5:401-15.
5. Schroeder SA, Kenders K, Cooper JK, et al. Use of laboratory tests and pharmaceuticals. Variation among physicians and effect of cost audit on subsequent use. JAMA 1973;225:969-73.
6. Bugter-Maessen AM, Winkens RA, Grol RP, et al. Factors predicting differences among general practitioners in test ordering behaviour and in the response to feedback on test requests. Fam Pract 1996;13:254-8.
7. Epstein AM, McNeil BJ. Relationship of beliefs and behavior in test ordering. Am J Med 1986;80:865-70.
8. Hartley RM, Epstein AM, Harris CM, et al. Differences in ambulatory test ordering in England and America. Role of doctors' beliefs and attitudes. Am J Med 1987;82:513-17.
9. Williams SV, Eisenberg JM, Pascale LA, et al. Physicians' perceptions about unnecessary diagnostic testing. Inquiry 1982;19:363-70.
10. Bareford D, Hayling A. Inappropriate use of laboratory services: long term combined approach to modify request patterns. BMJ 1990;301:1305-7.
11. Beck JR. Does feedback reduce inappropriate test ordering? Arch Pathol Lab Med 1993;117:33-4.
12. Bush TM, Shlotzhauer TL, Grove W. Serum complements. Inappropriate use in patients with suspected rheumatic disease. Arch Intern Med 1993;153:2363-6.
13. Hyams KC. Inappropriate urine cultures in hospitalized patients receiving antibiotic therapy. Arch Intern Med 1987;147:48-9.
14. Perraro F, Rossi P, Liva C, et al. Inappropriate emergency test ordering in a general hospital: preliminary reports. Qual Assur Health Care 1992;4:77-81.
15. Tabriz MS, Riederer K, Baran J Jr, et al. Repeating blood cultures during hospital stay: practice pattern at a teaching hospital and a proposal for guidelines. Clin Microbiol Infect 2004;10:624-7.
16. Wu AH. Reducing the inappropriate utilization of clinical laboratory tests. Conn Med 1997;61:15-21.
17. Wong ET. Improving laboratory testing: can we get physicians to facus on outcome? Clin Chem 1995;41:1241-7.
18. Zaat JO, van Eijk JT. General practitioners' uncertainly, risk preference, and use of laboratory tests. Med Care 1992;30:846-54.
19. Little P, Cantrell T, Roberts L, et al. Why do GPs perform investigations? The medical and social agendas in arranging back X-rays. Fam Pract 1998;15:264-5.
20. McDonald IG, Daly J, Jelinek VM, et al. Opening Pandora's box: the unpredictability of reassurance by a normal test result. BMJ 1996;313:329-32.
21. Bates DW, Goldman L, Lee TH. Contaminant blood cultures and resource utilization. The true consequences of false-positive results. JAMA 1991;265:365-9.
22. Rang M. The Ulysses syndrome. Can Med Assoc J 1972;106:122-3.
23. Fineberg HV, Pearlman LA. Low-cost medical practices. Annu Rev Public Health 1982;3:225-48.
24. Lewis S, Foreman J. Low-cost diagnostic technologies and clinical outcomes. The impact of inappropriate utilization. Int J Technol Assess Health Care 1997;13:501-11.
25. Moloney TW, Rogers DE. Medical technology-a different view of the contentious debate over costs. N Engl J Med 1979;301:1413-19.
26. Thamer M, Fitzpatrick KJ, Perry S. Medical and surgical supply costs. Case study of a costly low-cost technology. Int J Technol Assess Health Care 1997;13:526-36.
27. Oxman AD, Thomson MA, Davis DA, et al. No magic bullets: a systematic review of 102 trials of interventions to improve professional practice. Can Med Assoc J 1995;153:1423-31.
28. Verstappen WH, ter Riet G, Dubois WI, et al. Variation in test ordering behaviour of GPs: professional or context-related factors? Fam Pract 2004;21:387-95.
29. Axt-Adam P, van der Wouden JC, van der DE. Influencing behavior of physicians ordering laboratory tests: a literature study. Med Care 1993;31:784-94.
30. van Walraven C, Naylor CD. Do we know what inappropriate laboratory utilization is? A systematic review of laboratory clinical audits. JAMA 1998;280:550-8.
31. Werner M. Appropriate utilization and cost control of the hospital laboratory: panel testing and repeat orders. Clin Chim Acta 1995;233:1-17.
32. Valenstein P, Leiken A, Lehmann C. Test-ordering by multiple physicians increases unnecessary laboratory examinations. Arch Pathol Lab Med 1988;112:238-41.
33. Tierney WM, McDonald G, Martin DK, et al. Computerized display of past test results. Effect on outpatient testing. Ann Intern Med 1987;107:569-74.
34. Tierney WM, McDonald G, Hui SL, et al. Computer predictions of abnormal test results. Effects on outpatient testing. JAMA 1988;259:1194-8.
35. Bates DW, Kuperman G, Teich JM. Computerized physician order entry and quality of care. Qual Manag Health Care 1994;2:18-27.
36. Sittig DF, Stead WW. Computer-based physician order entry: the state of the art. J Am Med inform Assoc 1994;1:108-23.
37. Tierney WM, Miller ME, Overhage JM, et al. Physician inpatient order writing on microcomputer workstations. Effects on resource utilization. JAMA 1993;269:379-83.
38. Johnston ME, Langton KB, Haynes RB, et al. Effects of computer-based clinical decision support systems on clinician performance and patient outcome. A critical appraisal of research. Ann Intern Med 1994;120:135-42.
39. Bunting PS, van Walraven C. Effect of a controlled feedback intervention on laboratory test ordering by community physicians. Clin Chem 2004;50:321-6.
40. Grimshaw JM, Russell IT. Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet 1993;342:1317-22.
41. Neilson EG, Johnson KB, Rosenbloom ST, et al. The impact of peer management on test-ordering behavior. Ann Intern Med 2004;141:196-204.
42. Solomon DH, Hashimoto H, Daltroy L, et al. Techniques to improve physicians' use of diagnostic tests: a new conceptual framework. JAMA 1998;280:2020-7.
43. Huissoon AP, Carlton SA. Unnecessary repeat requesting of tests in a university teaching hospital immunology laboratory: an audit. J Clin Pathol 2002;55:78.
44. Lane SK, Gravel JW Jr. Clinical utility of common serum rheumatologic tests. Am Fam Physician 2002;65:1073-80.
45. Moder KG. Use and interpretation of rheumatologic tests: a guide for clinicians. Mayo Clin Proc 1996;71:391-6.
46. Tozzoli R, Bizzaro N, Tonutti E, et al. Guidelines for the laboratory use of autoantibody tests in the diagnosis and monitoring of autoimmune rheumatic diseases. Am J Clin Pathol 2002;117:316-24.
47. Tampoia M, Fontana A, Di Serio F, et al. Application of a diagnostic algorithm in autoantibody testing: assessment of clinical effectiveness and economic efficiency. Clin Chim Acta 2003;333:181-3.
48. Gama R, Nightingale PG, Broughton PM, et al. Modifying the request behaviour of clinicians. J Clin Pathol 1992;45:248-9.
49. Blecher TE. Modifying the request behaviour of clinicians. J Clin Pathol 1992;45:742-3.
50. Kavanaugh A, Tomar R, Reveille J, et al. Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. American College of Pathologists. Arch Pathol Lab Med 2000;124:71-81.
51. Ioannidis JP, Katsifis GE, Stavropoulos ED, et al. Evaluation of the association of autoantibodies with mortality in the very elderly: a cohort study. Rheumatology (Oxford) 2003;42:357-61.
52. Shmerling RH. Rheumatic disease: choosing the most useful diagnostic tests. Geriatrics 1996;51:22-30, 32.
53. Alvarez F, Berg PA, Bianchi FB, et al. International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999;31:929-38.
54. Ben Ari Z, Czaja AJ. Autoimmune hepatitis and its variant syndromes. Gut 2001;49:589-94.
55. Czaja AJ, Carpenter HA. Histological findings in chronic hepatitis C with autoimmune features. Hepatology 1997;26:459-66.
56. Czaja AJ, Homburger HA. Autoantibodies in liver disease. Gastroenterology 2001;120:239-49.
57. Czaja AJ, Freese DK. Diagnosis and treatment of autoimmune hepatitis. Hepatology 2002;36:479-7.
58. Johnson PJ, McFarlane IG. Meeting report: international autoimmune hepatitis group. Hepatology 1993;18:998-1005.
59. Miyakawa H, Kawaguchi N, Abe K, et al. Serial changes of serum anti-M2 proteins in patients with primary biliary cirrhosis: a follow-up study by immunoblotting. Hepatol Res 1999;13:143-52.
60. Talwalkar JA, Lindor KD. Primary biliary cirrhosis. Lancet 2003;362:53-61.
61. Irvine WJ. Immunologic aspects of pernicious anemia. N Engl J Med 1965;273:432-8.
62. Toh BH, van Driel IR, Gleeson PA. Pernicious anemia. N Engl J Med 1997;337:1441-8.
63. Chapel HM. Consensus on diagnosis and management of primary antibody deficiencies. Consensus panel for the diagnosis and management of primary antibody deficiencies. BMJ 1994;308:581-5.
64. Anonymous. Consensus document for the diagnosis and management of patients with primary antibody immunodeficiencies. London: The Marks and Spencer Publications Unit of the Royal College of Pathologists, 1995.
65. European Group of Tumour Markers (ETGM). Consensus recommendations. Anticancer Res 1999;19:2784-820.
66. Singapore Ministry of Health-National Government Agency (non-US), ed. Chronic hepatitis B infection. Singapore: National Guideline Clearinghouse, 2003.
67. Duffy MJ, McGuire P, McSweeney J. Guidelines for the use of tumour markers, 2nd ed. Association of Clinical Biochemists in Ireland, 2000 (http://www.acbi.ie/acbi-tmk.html).
68. Gebo KA, Chander G, Jenckes MW, et al. Screening tests for hepatocellular carcinoma in patients with chronic hepatitis C: a systematic review. Hepatology 2002;36:S84-92.
69. National Cancer Institute. Hepatocellular cancer: screening. Last accessed February 2005 (http://www.cancer.gov/cancerinfo/pdq/screening/ hepatocellular/healthprofessional).
70. Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. Adopted on May 17 1996 by the American Society of Clinical Oncology. J Clin Oncol 1996;14:2843-77.
71. Tumour markers in gastrointestinal cancers-EGTM recommendations. European group on tumour markers. Anticancer Res 1999;19:2811-15.
72. ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of advanced colorectal cancer. Ann Oncol 2001;12:1055.
73. ESMO minimum clinical recommendations for diagnosis, adjuvant treatment and follow-up of colon cancer. Ann Oncol 2001;12:1053-4.
74. Anthony T, Simmang C, Hyman N, et al. Practice parameters for the surveillance and follow-up of patients with colon and rectal cancer. Dis Colon Rectum 2004;47:807-17.
75. Bast RC Jr, Ravdin P, Hayes DF, et al. 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 2001;19:1865-78.
76. Compton CC, Fielding LP, Burgart U, et al. Prognostic factors in colorectal cancer. College of American Pathologists consensus statement 1999. Arch Pathol Lab Med 2000;124:979-94.
77. Watine J, Friedberg B. Laboratory variables and stratification of metastatic colorectal cancer patients: recommendations for therapeutic trials and for clinical practice guidelines. Clin Chim Acta 2004;345:1-15.
78. ESMO minimum clinical recommendations for diagnosis, adjuvant treatment and follow-up of primary breast cancer. Ann Oncol 2001;12:1047-48.
79. Tumour markers in prostate cancer: EGTM recommendations. European group on tumour markers. Anticancer Res 1999;19:2799-801.
80. Bates DW, Boyle DL, Rittenberg E, et al. What proportion of common diagnostic tests appear redundant? Am J Med l998;104:361-8.
81. Eisenberg JM. Doctors' decisions and the cost of medical care. Ann Arbor, MI: Health Administration Press, 1986.
82. Davidoff F, Goodspeed R, Clive J. Changing test ordering behavior. A randomized controlled trial comparing probabilistic reasoning with cost-containment education. Med Care 1989;27:45-58.
83. Mozes B, Lubin D, Modan B, et al. Evaluation of an intervention aimed at reducing inappropriate use of preoperative blood coagulation tests. Arch Intern Med 1989;149:1836-8.
84. Thompson RS, Kirz HL, Gold RA. Changes in physician behavior and cost savings associated with organizational recommendations on the use of "routine" chest X rays and multichannel blood tests. Prev Med 1983;12:385-96.
85. Zaat JO, van Eijk JT, Bonte HA. Laboratory test form design influences test ordering by general practitioners in the Netherlands. Med Care 1992;30:189-98.
86. Durand-Zaleski I, Rymer JC, Roudot-Thoraval F, et al. Reducing unnecessary laboratory use with new test request form: example of tumour markers. Lancet 1993;342:150-3.
87. Wong ET, McCarron MM, Shaw ST Jr. Ordering of laboratory tests in a teaching hospital. Can it be improved? JAMA 1983;249:3076-80.
88. Novich M, Gillis L, Tauber AI. The laboratory test justified. An effective means to reduce routine laboratory testing. Am J Clin Pathol 1985;84:756-9.
89. Dixon RH, Laszlo J. Utilization of clinical chemistry services by medical house staff. An analysis. Arch Intern Med 1974;134:1064-7.
90. Eisenberg JM. An educational program to modify laboratory use by house staff. J Med Educ 1977;52:578-81.
91. van Walraven C, Goel V, Chan B. Effect of population-based interventions on laboratory utilization: a time-series analysis. JAMA 1998;280:2028-33.